Form 4: Organon & Co. Director Whiteford Reports Phantom Stock Acquisition

Director Grace Puma Whiteford reports acquiring phantom stock units in Organon & Co. through a non-employee director savings plan.

Summary

• Grace Puma Whiteford, a director of Organon & Co., filed a Form 4 detailing changes in beneficial ownership.
• The report indicates the acquisition of 9,638.554 phantom stock units on June 7, 2024, under the Organon Non-Employee Director Savings Plan.
• These phantom stock units are economically equivalent to shares of Organon common stock and will be settled in cash upon termination of service as a director.
• The price of the phantom stock is $20.75.
• Whiteford's holdings include phantom stock acquired through dividend reinvestment transactions on June 15, 2023, September 14, 2023, December 14, 2023 and March 14, 2024.
• Following the reported transaction, Whiteford beneficially owns 36,454.813 derivative securities.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing detailing an insider transaction. It doesn't inherently convey strong positive or negative sentiment, but the director's acquisition of phantom stock could be interpreted as a mildly positive signal.

Positives

• The acquisition of phantom stock by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure related to insider transactions, common for publicly traded companies like Organon & Co. It provides transparency into the holdings and transactions of company directors.

Comparison to Industry Standards

• Director compensation packages often include equity-based awards like phantom stock to align their interests with shareholders.
• The specifics of Organon's Non-Employee Director Savings Plan would need to be compared to similar plans at peer companies to assess its competitiveness.
• Companies like Pfizer and Merck, which have spun off or have similar business models to Organon, could be used as benchmarks for director compensation structures.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals director confidence.

Key Dates